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Abstract In eukaryotes, mismatch recognition is thought to be
mediated by two heterodimers, hMutSK (hMSH2+hMSH6),
which preferentially binds to base-base mismatches and hMutSL
(hMSH2+hMSH3), which binds to insertion/deletion loops. We
studied these mismatch binding activities in several human cell
lines with a gel-shift assay using various mismatch oligonucleo-
tides as substrates. Both hMutSK and hMutSL activities could be
detected in various human cell lines. In cells with amplified copies
of the hMSH3 gene, a large increase in hMutSL and a reduction
in hMutSK were observed. To identify the composition of each
mismatch binding complex, the protein-DNA complexes were
transferred from gel-shift polyacrylamide gel to a polyvinylidene
difluoride membrane and were subjected to immunoblot analysis
with an enhanced chemiluminescence protein detection system.
The results clearly demonstrated that hMutSK detected by the
gel-shift assay was composed of hMSH2 and hMSH6, while
hMutSL was composed of hMSH2 and hMSH3. Our data,
therefore, support a model whereby formation of hMutSK and
hMutSL is mutually regulated. Combination of a gel-shift assay
with immunoblotting (shift-Western assay) proved to be a highly
sensitive technique and should be useful for studying the
interactions between DNA and binding proteins, including
DNA mismatch recognition.
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1. Introduction
Mismatch repair (MMR) is important for maintaining the
genome stability in many species [1,2]. Its mechanism has been
extensively studied in Escherichia coli, where it was observed
that MutS has a mismatch binding activity and is an essential
component of mismatch recognition, the ¢rst step in the
MMR pathway. In human, a number of MutS homologues
(hMSH) have been identi¢ed [3^8]. Using a baculovirus ex-
pression system, we previously showed that hMutSK, a heter-
odimer composed of hMSH2 and hMSH6, preferentially
binds to DNA heteroduplexes with base-base mismatches
and one nucleotide insertion/deletion loops (IDLs), whereas
hMutSL, composed of hMSH2 and hMSH3, binds to DNA
heteroduplexes with 2^4 nucleotide IDLs [9]. These hetero-
dimers were recently puri¢ed from HeLa cells [10] and
hMutSK was shown to restore base-base mismatch and one
nucleotide IDL repair activity to extracts derived from
hMSH2-de¢cient LoVo cells, while hMutSL restored only
the latter [10,11]. A similar restoration of MMR activity
was observed when recombinant hMutSK or hMutSL was
added to extracts from MMR-de¢cient HEC59 cells [12].
Thus, hMutSK and hMutSL appear to be essential for both
mismatch recognition and repair in human cells.
The ¢rst human gene encoding a MutS homologue,
hMSH3, was isolated in our laboratory [5]. It is located im-
mediately upstream of the gene encoding dihydrofolate reduc-
tase (DHFR) and is bidirectionally transcribed from the op-
posite strand of the promoter [13]. Because of their close
proximity, the DHFR and hMSH3 genes are often co-ampli-
¢ed when cells are treated with increasing concentrations of
methotrexate (MTX), a speci¢c inhibitor for DHFR. Recent
studies have shown that overexpression of hMSH3 sequesters
hMSH2 into hMutSL and inhibits the formation of hMutSK,
resulting in a defective base-base mismatch repair [10,12] and
suggesting that the formation of hMutSK and hMutSL are
mutually regulated in human cells.
In order to study MMR in various cancer cells, we wanted
to develop a rapid system for detecting mismatch binding
complexes using a gel-shift assay without having to purify
the complexes. While the existence of mismatch binding activ-
ity has been previously demonstrated in cell extracts using the
gel-shift assay [12], the identity of each component was not
completely characterized. In the present study, we establish
the shift-Western assay which could be used to detect individ-
ual components of mismatch binding complexes. This method
should enable study of the interaction between DNA and
binding proteins in crude cell lysates.
2. Materials and methods
2.1. Cell lines and nuclear extracts
MTX-resistant cell lines (HL60R, HeLaR and K562R) were main-
tained as described previously [5]. Each cell line contains more than
100 copies of the DHFR gene per cell. Nuclear extracts were prepared
from 1 liter cultures of cells according to the method of Dignam et al.
[14], dialyzed against bu¡er D containing 20 mM HEPES-OH (pH
7.8), 100 mM KCl, 0.2 mM EDTA, 1.0 mM dithiothreitol (DTT), 0.5
mM phenylmethanesulfonyl £uoride (PMSF), 0.05% NP-40 and 20%
glycerol and were stored in small aliquots at 380 ‡C. Protein concen-
trations were measured with Protein Assay Reagent (Bio-Rad) using
bovine serum albumin as a standard.
2.2. Expression and puri¢cation of recombinant hMutSL
Baculovirus vectors carrying cDNA inserts encoding hMSH2 or
hMSH3 were used to infect cultures of Sf9 cells. Recombinant hMutSL
was then puri¢ed as described previously [9].
2.3. Antibodies (Abs)
Anti-hMSH2 Ab (Santa Cruz) was raised in rabbits against a pep-
tide corresponding to amino acids 2^21. Anti-hMSH6 Ab, a gift from
Dr Josef Jiricny, was raised in rabbit against an overexpressed frag-
ment of hMSH6 corresponding to amino acids 750^928 [15]. Ab
against the full-length hMSH3 was prepared as follows: insoluble
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full-length hMSH3 expressed in a baculovirus system was solubilized
in 4 M guanidine HCl and dialyzed against bu¡er containing 0.5 M
NaCl, 0.05 M Tris-Cl (pH 7.5), 1 mM DTT, 1 mM EDTA, 1 mM
PMSF and sequentially reduced concentrations of urea (4^0 M). The
dialyzed protein was then used to raise Abs in rabbits. The IgG
fraction was puri¢ed from antiserum using E-Z-SEP Ab puri¢cation
kits (Amersham Pharmacia Biotech). Non-speci¢c binding in the anti-
hMSH3 IgG fraction was removed using a Hi-Trap NHS-activated
column (Amersham Pharmacia Biotech) on which E. coli-expressed
hMSH3 (Novagen, pET-15b) was immobilized.
2.4. Western analysis
Protein samples (50 Wg) were subjected to electrophoresis in 10%
SDS-polyacrylamide gels and then transferred to activated polyviny-
lidene di£uoride (PVDF) membranes (Immobilon-P, Millipore) for 15
h at 4 ‡C and 30 V. The transfer bu¡er contained 25 mM Tris, 192
mM glycine and 20% methanol. Membranes were then placed in bu¡-
er containing 10 mM Tris, 150 mM NaCl, 0.05% Tween 20 (TBS-T)
and 5% skim-milk and labelled with anti-hMSH2, anti-hMSH3 or
anti-hMSH6 Abs. The resultant bands were stained with goat anti-
rabbit IgG(H+L) conjugated with horseradish peroxidase (Promega),
detected using the ECL Plus Western blot detection system-II (Amer-
sham Pharmacia Biotech) and exposed to X-ray ¢lm (Fuji) for less
than 2 min.
2.5. Oligonucleotides and labelling
The following oligonucleotides were used. A synthetic 34-mer oli-
gonucleotide, 5P-AATTCCCGGGGATCCGTCGACCTGCAGCCA-
AGCT-3P, was labelled with [Q-33P]ATP at the 5P end using Megalabel
(Takara) and was annealed to its complementary oligonucleotide, 5P-
AGCTTGGCTGCAGGTYGACGGATCCCCGGGAATT-3P, where
Y represents pyrimidine (C, T: [16]). The labelled oligonucleotide
was also annealed with modi¢ed complementary oligonucleotides,
where Y = C and either A, AC or ACGT was inserted between T-15
and C-16, respectively, creating +1, +2 and +4 IDLs. Non-labelled
heteroduplexes were prepared in the same way and used for the shift-
Western assay described below.
2.6. Gel-shift assay
The binding reaction was carried out in 20 Wl of bu¡er containing
25 mM HEPES-OH (pH 8.0), 0.5 mM EDTA, 10% glycerol, 0.1 mM
ZnCl2, 0.5 mM DTT and 2 Wg calf thymus DNA (Gibco BRL).
Nuclear extracts (10 Wg) or recombinant hMutSL protein (1 Wg)
were added to the bu¡er and incubated for 10 min at room temper-
ature, after which 400 fmol of radiolabelled heteroduplexes was added
and further incubated for 30 min at room temperature. Then, 2 Wl of
20% (w/w) ¢coll was added to the reaction mixtures and half of each
sample was loaded onto a 5% polyacrylamide gel (160U160U2 mm)
that was pre-electrophoresed at 110 V for 90 min. Electrophoresis was
carried out in 0.25UTBE bu¡er (110 V, 4 ‡C) until the bromophenol
blue dye in a side lane migrated 9 cm (4.0^4.5 h). The gels were
subsequently dried and exposed to X-ray ¢lm (Fuji) for 2 days. To
examine the e¡ect of the Abs on the binding reaction, an IgG fraction
or antiserum was added to the reaction mixture and incubated for 40
min at 4‡C before the addition of radiolabelled substrates.
2.7. Shift-Western assay
Samples were prepared with unlabelled heteroduplexes and frac-
tionated by polyacrylamide gel electrophoresis as described in the
Section 2.6. After the electrophoresis, the gels were blotted on
PVDF membranes at room temperature for 3 h at 150 mA in a bu¡er
containing 25 mM Tris, 192 mM glycine, 5% methanol using a
semidry blotting apparatus (Amersham Pharmacia Biotech). For im-
munoreactive detection, membranes were blocked overnight at 4‡C in
TBS-T containing 5% skim milk. Bands were visualized using en-
hanced chemiluminescence (ECL) as described for the Western anal-
ysis. Ab stripping was carried out according to the manufacturer’s
instructions with the ECL Plus system.
3. Results
3.1. Mismatch binding activities in human cells
The nuclear extracts from HL60, HeLa and K562 (data not
shown) cells were incubated with radiolabelled heteroduplexes
and analyzed using the gel-shift assay (Fig. 1B, odd number
lanes). At least ¢ve shifted bands were detected. Band 3 was
seen with a control homoduplex (Fig. 1B, lane 1), but the
other four bands were mismatch-speci¢c and were completely
blocked in the presence of a 25-fold excess of non-labelled
substrate (data not show). The faint band 1 was seen with
heteroduplexes containing 1^4 nucleotide IDLs in HL60 and
HeLa cells (Fig. 1B, lanes 5, 7, 9 and 13), while band 2 was
clearly detected in all three cell types with heteroduplexes
containing G/T mismatches and one nucleotide IDLs (Fig.
1B, lanes 3, 5 and 11). This binding pattern suggests that
bands 1 and 2 correspond to binding complexes containing
hMutSL and hMutSK, respectively.
Fig. 1. Mismatch binding activity in human MTX-sensitive (S) and -resistant (R) cells. (A) Western blot analysis of three MutS homologues.
Nuclear extracts (50 Wg) from HL60S and HL60R cells were analyzed. Molecular weight markers (kDa) are drawn on the left. (B) Gel-shift as-
say. Nuclear extracts (10 Wg) from HL60S/R (lanes 1^10) and HeLaS/R (lanes 11^14) cells were incubated with various radiolabelled substrates
and analyzed as described in Section 2.
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3.2. Mismatch binding activities in MTX-resistant cells
We next studied mismatch binding activities in MTX-resist-
ant cells, where the hMSH3 and DHFR genes were co-ampli-
¢ed about 100-fold [5]. Overexpression of hMSH3 in MTX-
resistant cells was con¢rmed by Western analysis. As com-
pared to MTX-sensitive HL60 cells (HL60S), a large increase
in hMSH3 and a concomitant reduction in hMSH6 were de-
tected in MTX-resistant HL60 cells (HL60R). There was no
substantial di¡erence in hMSH2 levels between the two cell
lines (Fig. 1A). When the nuclear extracts from MTX-resist-
ant cells were incubated with heteroduplexes, there was a re-
markable increase in the density of band 1 (Fig. 1B, lanes 6, 8,
10 and 14). Band 2, by contrast, was barely detectable after
incubation with heteroduplexes containing G/T mismatches
and one nucleotide IDLs (Fig. 1B, lanes 4, 6 and 12).
3.3. Components of mismatch binding complexes
The components of mismatch binding complexes were
studied by exposing the complexes to the respective Ab
against each MutS homologue. Addition of anti-hMSH3
IgG diminished band 1 (Fig. 2, lanes 6, 8 and 10), whereas
band shift patterns were partially a¡ected by anti-hMSH2
IgG or anti-hMSH6 Ab (data not shown).
To identify the protein components of the complexes di-
rectly, we used the shift-Western assay in which shifted bands
were transferred to membranes and stained with the Abs.
Nuclear extracts were incubated with radiolabelled or unla-
belled substrates and applied side by side to the same gel. The
recombinant hMutSL protein expressed in the baculovirus
system was then added to the right hand side of each gel
half as a control (Fig. 3). After electrophoresis, the gel was
transferred to a membrane which was cut in two and the
membrane half containing radiolabelled substrates was ex-
posed to a X-ray ¢lm. The recombinant hMutSL showed a
mismatch-speci¢c band at a position identical to band 1 (Fig.
3A). The gel half containing unlabelled substrates was sequen-
tially incubated with anti-hMSH2 Ab (Fig. 3B-1), anti-
hMSH3 IgG (Fig. 3B-2) and anti-hMSH6 Ab (Fig. 3B-3),
after stripping the previously applied Ab. Proteins were de-
tected by staining with secondary Ab using the enhanced
chemiluminescence system. Incubation with Ab against
hMSH2 yielded two bands at positions identical to bands 1
and 2 in Fig. 3B-1, whereas incubation with Ab against
hMSH3 or hMSH6 each yielded a single band at a position
identical to band 1 or band 2, respectively (Fig. 3B-2 and -3).
The recombinant hMutSL was stained only with Ab against
hMSH2 or hMSH3 (Fig. 3B-1 and -2). The two other mis-
Fig. 2. The e¡ect of anti-hMSH3 IgG on hMutSL formation in a
gel-shift assay. Ab was added to the reaction mixtures in the even-
numbered lanes. The arrows on the right indicate the mismatch
binding complexes, hMutSK (K) and hMutSL (L), respectively.
Fig. 3. Identi¢cation of hMutSK and hMutSL binding activities using the shift-Western assay. (A) Gel-shift assay. Nuclear extracts from
HL60S cells or recombinant hMutSL (rhMutSL : lane 6) were incubated with various radiolabelled substrates. (B) Shift-Western assay. A similar
mixture of non-labelled substrates was simultaneously incubated and loaded onto the remaining half of the same gel. Protein-DNA complexes
were transferred to a PVDF membrane and the membrane was sequentially treated with anti-hMSH2 (B-1), anti-hMSH3 (B-2) and anti-
hMSH6 Abs (B-3).
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match-dependent bands (bands 4 and 5 in Fig. 1) were unla-
belled, indicating that those complexes did not contain
hMSH2, hMSH3 or hMSH6 and may not be involved in
MMR [17,18].
The above results directly demonstrate that band 1 corre-
sponds to hMutSL (hMSH2+hMSH3), while band 2 corre-
sponds to hMutSK (hMSH2+hMSH6). They also reveal the
mismatch binding-speci¢city of the two MutS heterodimers in
the cell : hMutSK (band 2) binds to G/T mismatches and one
nucleotide IDLs, while hMutSL (band 1) binds to heterodu-
plexes with 1^4 nucleotide IDLs. Redundant binding by
hMutSK and hMutSL was also observed with 1 and 2 nucleo-
tide IDL substrates (Fig. 3A, lanes 3 and 4), as has been seen
with recombinant complexes [9].
4. Discussion
In the present study, we established the shift-Western assay
and analyzed mismatch binding complexes. Our results clearly
demonstrate that the G/T mismatch and one nucleotide IDL
binding complex is composed of hMSH2 and hMSH6 in hu-
man cells, while the 1^4 nucleotide IDL mismatch binding
complex is composed of hMSH2 and hMSH3. This method
enabled us to quickly distinguish multiple mismatch binding
complexes even when their molecular masses are very similar
(e.g. hMutSK is 265 kDa and hMutSL is 232 kDa). Thus, the
shift-Western assay should be useful for studying the MMR
activity in a variety of cell types.
Gel-shift assays are widely used to study protein-DNA in-
teractions. This method is simple to perform and suitable for
quantitative analysis of large numbers of samples. However,
its drawbacks are that there may be numerous, non-speci¢c
band shifts and the electrophoretic patterns are easily a¡ected
by the experimental conditions. Consequently, identi¢cation
of the protein components in the shifted bands is essential
for interpretation of the results and Abs against putative pro-
tein components are included in the reaction mixtures. None-
theless, the results are frequently inconsistent. Ab-protein
binding may result in either inhibition of protein-DNA bind-
ing or supershift of the complexes, depending upon the loca-
tion of the epitope on the protein and nature of the Ab.
Moreover, the a⁄nity of some Abs appears to be too low
for them to be useful. In our experiments, complete depletion
of the hMutSL-IDL complex was observed when anti-MSH3
IgG was included. However, only partial reduction of the
intensities of hMutSL-IDL and hMutSK-G/T and one nucleo-
tide IDL were seen when anti-MSH2 and anti-MSH6 Abs
were used.
The shift-Western assay was designed to detect the presence
and the relative abundance of proteins within speci¢c protein-
DNA complexes [19]. Combination with an ECL detection
system signi¢cantly increased the sensitivity of the assay and
enabled the identi¢cation of proteins even when the binding
a⁄nity of the Ab was low. The anti-hMSH2 and anti-hMSH6
Abs used in our study were unable to supershift protein-DNA
complexes, but were su⁄cient for detection of protein compo-
nents in a shift-Western assay. Thus, this technique should be
useful for studying protein-DNA complexes containing multi-
ple protein components or multiple binding sites on DNA
fragments.
The data strongly support a model recently proposed by
Drummond et al. [10], which postulates that formation of
hMutSK and hMutSL are mutually regulated and that
hMutSK and hMutSL heterodimers compete for a limited
quantity of hMSH2. In the presence of excess hMSH3, avail-
able hMSH2 would be used up through generation of hMutSL
and would, therefore, be unavailable for generation of
hMutSK. Lack of hMutSK activity was previously found to
result in defective repair of base-base mismatches in HL60R
cells [10,12]. Our experiments show that this phenomenon also
occurs in other MTX-resistant HeLaR and K562R cells.
The ¢rst mutS homologue discovered in humans was
hMSH3 [5], but the function of its putative product has re-
mained uncertain until recently. Now, there are several ¢nd-
ings suggesting that hMSH3 may be involved in carcinogene-
sis. First, decreased expression of hMSH3 was found in bone
marrow cells of some patients with hematological malignan-
cies [20]. Second, one base deletion and insertion at the (A)8
track in exon 7 of the hMSH3 gene were found in various
human tumors and in cell lines with microsatellite instability
[21^23]. Thus, it is possible that this mutation causes the ge-
nomic instability at the 1^4 nucleotide IDLs seen in at least
some cancer cells [22]. Mutation of the hMSH3 gene may also
be the result of an earlier MMR error. Once the mutation is
introduced, the defective hMSH3 activity may enhance ge-
nomic instability and accelerate tumor progression. Finally,
our study suggests a third possibility. MTX is a widely used
anti-cancer agent, but its e⁄cacy is often diminished by the
development of cell-resistance due to ampli¢cation of the
DHFR gene [13,24]. It may, therefore, be that secondary tu-
mors developing after treatment of the primary cancer derive
from MTX-resistant cells in which overexpression of hMutSL
has resulted in a defective hMutSK activity.
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